CerFlux offers personalized medicine technology for matching treatments to tumors.
CerFlux has raised $275K in total funding. The most recent round was Grant. The last funding was announced in August 2023.
CerFlux's investors include National Science Foundation, Innovate Alabama.
CerFlux is headquartered in Birmingham, United States.
CerFlux offers personalized medicine technology for matching treatments to tumors.
CerFlux is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CerFlux — Funding & Investors." VCBacked, August 3, 2023, https://www.vcbacked.co/company/cerflux. Accessed August 14, 2026.
VCBacked. (2023). CerFlux — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cerflux
{{cite web |title=CerFlux — Funding & Investors |url=https://www.vcbacked.co/company/cerflux |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated